Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
  • Careers & studies
        • Careers & Studies

          Take the next step in your career with Centenary, Australia’s foremost clinically integrated medical research institute

          Learn more

        • Career opportunities
        • Life at Centenary
        • Post-Doctorate Research
        • PhD
        • Masters
        • Honours
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Contact
  • Donate
    Centenary Institute > News > Aspirin could make urinary tract infections worse

Aspirin could make urinary tract infections worse

Date time 15 November, 2021
News Type News type Media release
New research by the Centenary Institute suggests that commonly prescribed anticoagulants – medicines, such as aspirin, that help prevent blood clots – may make urinary tract infections (UTIs) more severe.

New research by the Centenary Institute suggests that commonly prescribed anticoagulants – medicines, such as aspirin, that help prevent blood clots – may make urinary tract infections (UTIs) more severe.

One of the most common infections worldwide, UTIs are not normally serious or life threatening but in rare cases can progress into sepsis, also known as septicaemia.

In older people the risk of developing severe UTIs often overlaps with conditions that require anticoagulant treatment.

Researchers found that in zebrafish, the commonly prescribed anticoagulant medications – specifically aspirin and warfarin – increased UTI severity.

“We commonly use zebrafish in medical research to better understand diseases in order to find cures,” said Dr Stefan Oehlers, Head of the Centenary Institute’s Immune-Vascular Interactions Laboratory and study senior author.

“Zebrafish share 70 percent of the same genes as people and 84 percent of human genes known to be associated with human diseases have a zebrafish counterpart. This makes them perfect for study.”

Dr Oehlers said that UTI-associated sepsis is most often caused by uropathogenic Escherichia coli (UPEC), a bacterium that first infects the urinary system.

“We used the zebrafish to model the sepsis phase of UPEC infection,” said Dr Oehlers.

“Using this model we demonstrated that commonly used anticoagulant medicines reduced zebrafish survival and increased UPEC bacteria burden.”

The researchers believe that the administration of the anticoagulant medications prevented natural clotting that would have helped to contain bacteria in the blood.

The research was published in the journal Microbiological Research.

Publication: Common anti-haemostatic medications increase the severity of systemic infection by uropathogenic Escherichia coli.

Themes

  • Inflammation

    Inflammation

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Common anti-haemostatic medications increase the severity of systemic infection by uropathogenic Escherichia coli.

Download

Recent Stories

  • 2GB Healthy Living program interviews Dr Elinor Hortle

    Dr Elinor Hortle, medical researcher at the Centenary Institute has been interviewed on Sydney radio 2GB’s Healthy Living program, discussing her latest findings on tackling mycobacterial infections. Responsible for diseases that include tuberculosis (TB), leprosy and serious skin ulcerations, mycobacterial infections cause significant harm and mortality to human health. Approximately 1.5 million people die each ...
    News Type: Media coverage
    Date 18 May 2022
  • World-first study reveals why people with COPD are more susceptible to COVID-19

    Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19. The findings, reported in the American Journal of Respiratory and Critical Care Medicine,could lead to the development of new therapeutic interventions that ...
    News Type: Media release
    Date 17 May 2022
  • New discovery may hold key to fighting deadly infections

    Centenary Institute research has revealed new insight into tackling mycobacterial infections which are responsible for chronic diseases that include tuberculosis (TB), leprosy and serious skin ulcerations.
    News Type: Media release
    Date 12 May 2022
  • Research Australia’s ‘Inspire Magazine’ features Professor Chris Semsarian AM

    Professor Chris Semsarian AM, Head of the Centenary Institute’s Agnes Ginges Centre for Molecular Cardiology, has featured in an article in Research Australia’s Inspire Magazine outlining the importance of philanthropy to medical research. The article highlights how the philanthropic support of Mrs Agnes Ginges and her husband, the late Mr Berel Ginges (facilitated by eminent ...
    News Type: Media coverage
    Date 03 May 2022

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Laboratories
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram